Overview
Paris, July 7, 2022 – McDermott Will & Emery advised Advicenne, a pharmaceutical company specializing in the development and commercialization of innovative treatments for those suffering from rare renal diseases, on its exclusive distribution agreement with Taïba Healthcare, a pharmaceutical company based in the Sultanate of Oman, for the commercialization of Sibnayal® in selected Middle East countries.
The McDermott team that advised Advicenne comprised:
- Emmanuelle Trombe, partner and Edouard Becker, associate.
